Group 1 - The core viewpoint of the articles emphasizes the implementation of a drug traceability code system, which is mandatory for all pharmacies and medical institutions in China, affecting the entire pharmaceutical supply chain [1][2][4] - The traceability code serves as an "electronic ID" for each drug, ensuring that each box of medicine has a unique scan record, which helps in identifying counterfeit or returned drugs [2][3] - As of June 16, 2023, the national medical insurance platform has collected 41.828 billion traceability code records, covering over 99% of medical institutions, with approximately 5 million consumers checking drug authenticity daily [2][3] Group 2 - The new system will transition to a "scan for settlement" model by July 1, 2025, and full traceability code coverage is expected by January 1, 2026, marking a significant shift in drug distribution and medical insurance regulation [2][4][5] - The introduction of the traceability code is expected to increase compliance costs for pharmacies and medical institutions, as they will need to upgrade systems and processes to ensure proper scanning and data collection [6][7] - The traceability code is anticipated to help pharmaceutical companies combat the issue of "returned drugs," thereby protecting brand reputation and maintaining profit margins, while also promoting sustainable development in the industry [7]
@所有购药人!今起不扫码医保不结算,还有哪些影响?
Di Yi Cai Jing·2025-07-01 05:12